Multiple Sclerosis in Pregnancy: A Commentary on Disease Modification and Symptomatic Drug Therapies

Multiple sclerosis (MS) frequently affects women of childbearing age, and an increasing number of disease-modifying therapies are available. However, a consequence of this is that women and clinicians face complex shared decisions surrounding disease-modifying therapy use in pregnancy and postpartum...

Descripción completa

Detalles Bibliográficos
Autores principales: Iyer, Priyanka, Dobson, Ruth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2022
Materias:
Commentary
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837363/
https://www.ncbi.nlm.nih.gov/pubmed/36443593
http://dx.doi.org/10.1007/s40120-022-00421-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9837363/
https://www.ncbi.nlm.nih.gov/pubmed/36443593
http://dx.doi.org/10.1007/s40120-022-00421-0

Ejemplares similares